This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Health insurers in the private Medicare business have a big incentive to diagnose their members with lots of health conditions: The government pays them more money. A new study shows the extent to which the biggest player in that business, UnitedHealth Group , stands out from the rest for its prowess at raking in extra cash from that program. Medicare Advantage insurers pulled in an estimated $33 billion in additional payment from the government in 2021 as a result of these extra diagnoses
Robert F. Kennedy Jr. will likely delay his appearance before the Senate’s health committee by several weeks, even as he makes historic changes to the Department of Health and Human Services and contends with a surging measles outbreak. Senate health committee Chair Bill Cassidy (R-La.) and ranking member Bernie Sanders (I-Vt.) publicly asked the secretary to appear on April 10.
How do pharma brands cut through the noise and bring the right audiences to their digital doorstep? As digital channels continue to expand, identifying and optimizing the best traffic drivers has become more critical than ever for pharma marketing teams. In this article, well unpack the most effective sources of website traffic in 2025from organic search to paid campaignsand explore how marketing leaders can turn clicks into meaningful engagement.
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
SALT LAKE CITY — U.S. Health Secretary Robert F. Kennedy Jr. on Monday said he plans to tell the Centers for Disease Control and Prevention soon to stop recommending fluoridation in communities nationwide. Kennedy also said he’s assembling a task force to focus on the issue. Also on Monday, the U.S. Environmental Protection Agency announced it is reviewing “new scientific information” on potential health risks of fluoride in drinking water.
Fixed-dose combinations (FDCs), which contain two or more active ingredients in a single dosage form, have seen a significant rise in production and usage across the pharmaceutical industry. This increase has been driven by several factors, including the need for simplified treatment regimens, efforts to improve patient adherence, and the demand for cost-effective therapeutic solutions.
Fixed-dose combinations (FDCs), which contain two or more active ingredients in a single dosage form, have seen a significant rise in production and usage across the pharmaceutical industry. This increase has been driven by several factors, including the need for simplified treatment regimens, efforts to improve patient adherence, and the demand for cost-effective therapeutic solutions.
JEFFERSON CITY, Mo. — Global agrochemical manufacturer Bayer has asked the U.S. Supreme Court to decide whether federal law preempts thousands of state lawsuits alleging it failed to warn people that its popular weedkiller could cause cancer. Bayer’s new request to the nation’s highest court comes as it is simultaneously pursing legislation in several states seeking to erect a legal shield against lawsuits targeting Roundup, a commonly used weedkiller for both fa
HELP committee chair Bill Cassidy, R-La., had invited Kennedy to testify April 10 on the sweeping layoffs of federal health workers Kennedy ordered last month. A hearing could still take place later.
For more than four decades since the passage of the Hatch-Waxman Act, the U.S. generic drug market has provided patients with low-cost alternatives to brand-name medicines, saving the health care system billions while preserving incentives for biopharmaceutical innovation. Today, low-cost generics account for nine out of every 10 prescriptions dispensed in the United States and come with an average copay of about six dollars.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
This decision is based on the randomised MITIGATE trial data, which showed the antibodys potential to reduce disease activity by minimising flares in individuals, upholding its established safety profile as well as efficacy. The trial was structured to assess the antibodys safety and efficacy against a placebo in minimising the flare risk in individuals with IgG4-RD.
Come together with leaders from the pharmaceutical, biotechnology, and diagnostic industries to unpack huge changes at the American Conference Institutes 23rd Advanced Summit on Life Sciences Patents , which is scheduled to take place from May 19-20, 2025 at the New York Bar Association in New York, NY. In a year of major change and outstanding questions, growing scrutiny on patent protection and drug pricing, and uncertainty around global price control measures and the Inflation Reduction Act,
DHL Group has announced a strategic investment of 2 billion over the next five years to scale its logistics infrastructure for the life sciences and healthcare sector. This investment is part of the Groups Strategy 2030 and is aimed at enabling healthcare customers to expand operations, support innovation, and deliver patient services across key global regions.
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
As single use becomes more prevalent, end users are looking for more customization, and regulators are refining their rules, says Todd Andrews of CPC in an interview with Pharmaceutical Technology Group.
The Scottish Medicines Consortium (SMC) has approved bimekizumab for adults with active moderate to severe hidradenitis suppurativa (HS) who have not responded to conventional systemic therapies. This approval makes Scotland the first country in the UK to offer bimekizumab for HS patients. HS is a chronic inflammatory skin condition affecting 0.77% of the UK population.
Best vitamins and supplements for millions of people who take prescription medications every day to manage health conditions like high blood pressure, diabetes, and acid reflux. While these drugs are essential, they can also reduce the body’s levels of important vitamins and minerals.
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
The global healthcare sector recorded a downturn in mergers and acquisitions (M&A) and venture capital (VC) investments in March 2025, according to the latest monthly analysis from GlobalData. M&A activity in March 2025 comprised 85 deals totalling $7.6 billion, reflecting a 46.9 per cent decline in value compared to the same month in 2024. This also falls below the 12-month average (March 2024 to February 2025) of 98 deals worth $13.2 billion.
“We, like so many others, have been forced to take steps to extend our cash runway,” said Tango’s CEO, citing the “extremely challenging financial markets.
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
In the second part of her video interview with Pharma Commerce Editor Nicholas Saraceno, Kimberly Westrich, chief strategy officer at the National Pharmaceutical Council, describes how accumulators, maximizers, and AFPs are impacting patients, manufacturers, and healthcare ecosystems, and how that all ties into the presentation she participated in.
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Study results in a rare form of obesity could help the company expand use of Imcivree, which is approved for two genetically driven forms of excess weight.
Tirzepatide-treated patients with chronic kidney disease (CKD), obesity, and heart failure with preserved ejection fraction (HFpEF) had improved renal function both by cystatin C and creatinine.
55
55
Input your email to sign up, or if you already have an account, log in here!
Enter your email address to reset your password. A temporary password will be e‑mailed to you.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
363 
Let's personalize your content